thiazoles has been researched along with af 150 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brandeis, R; Chapman, S; Fisher, A; Michaelson, DM; Pittel, Z | 1 |
| Fisher, A; Genis, I; Michaelson, DM | 1 |
| Ruske, AC; White, KG | 1 |
| Fisher, A | 1 |
| Beach, TG; Fisher, A; Potter, PE; Sue, LI; Walker, DG | 1 |
| Bar-Ner, N; Brandeis, R; Egozi, I; Fisher, A; Haring, R; Kliger-Spatz, M; Marcovitch, I; Natan, N; Pittel, Z; Sonego, H | 1 |
2 review(s) available for thiazoles and af 150
| Article | Year |
|---|---|
Therapeutic strategies in Alzheimer's disease: M1 muscarinic agonists.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Carbamates; Cheirogaleidae; Disease Models, Animal; Humans; Muscarinic Agonists; Neuroprotective Agents; Phenylcarbamates; Piperidines; Receptor, Muscarinic M1; Receptors, Muscarinic; Rivastigmine; Signal Transduction; tau Proteins; Thiazoles | 2000 |
M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer's disease: implications in future therapy.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Brain; Cell Death; Disease Models, Animal; Down-Regulation; Humans; Memory Disorders; Mice; Muscarinic Agonists; Oxidative Stress; Piperidines; Quinuclidines; Receptor, Muscarinic M1; Spiro Compounds; tau Proteins; Thiazoles; Thiophenes | 2003 |
4 other study(ies) available for thiazoles and af 150
| Article | Year |
|---|---|
M1 muscarinic agonist treatment reverses cognitive and cholinergic impairments of apolipoprotein E-deficient mice.
Topics: Acetylcholinesterase; Animals; Apolipoproteins E; Brain; Choline O-Acetyltransferase; Cholinergic Fibers; Cognition; Cognition Disorders; Male; Maze Learning; Mice; Mice, Knockout; Muscarinic Agonists; Piperidines; Reaction Time; Swimming; Thiazoles | 1998 |
Site-specific dephosphorylation of tau of apolipoprotein E-deficient and control mice by M1 muscarinic agonist treatment.
Topics: Animals; Antibodies, Monoclonal; Apolipoproteins E; Blotting, Western; Brain Chemistry; Epitopes; Male; Mice; Mice, Knockout; Muscarinic Agonists; Phosphorylation; Piperidines; Receptor, Muscarinic M1; Receptors, Muscarinic; tau Proteins; Thiazoles | 1999 |
Facilitation of memory performance by a novel muscarinic agonist in young and old rats.
Topics: Aging; Algorithms; Animals; Cognition; Female; Memory; Muscarinic Agonists; Piperidines; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; Receptors, Muscarinic; Thiazoles | 1999 |
Reduction of cerebrospinal fluid amyloid beta after systemic administration of M1 muscarinic agonists.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Brain; Cerebrospinal Fluid; Female; Muscarinic Agonists; Neurons; Peptide Fragments; Piperidines; Quinuclidines; Rabbits; Receptor, Muscarinic M1; Receptors, Muscarinic; Thiazoles; Thiophenes | 2001 |